Skip to main content

229 publications

Name Date Type Actions

Availability of the 2023 universal registration document

On 24 April 2024, Vetoquinol filed its 2022 Universal Registration Document with the Autorité des Marchés Financiers (AMF) in ESEF (European Single Electronic Format).

24/04/2024 Public releases

Universal registration document 2023 XBRL version

Universal Registration Document including the Annual Financial Report

24/04/2024 Reference document

Universal registration document 2023

Universal Registration Document including the Annual Financial Report

24/04/2024 Reference document

Buyback programs - March 2024

Monthly communication regarding buyback programs

04/04/2024 Description of buyback programs

2023 ANNUAL RESULTS

Annual sales: €529m (stable at constant exchange rates)
Essentials sales: €313m (+4.5% at constant exchange rates)
Net income - Group share: €56m (10.5% of sales)
EBITDA: €113m (21.3% of sales)
Free cash-flow: €89m

20/03/2024 Public releases

Buyback programs – January 2024

Monthly communication regarding buyback programs

02/02/2024 Description of buyback programs

Annual sales 2023: €529 million

Annual Sales of Essential products: €313 million (up 4.5% at constant exchange rates)

24/01/2024 Public releases

Buyback programs - November 2023

Monthly communication regarding buyback programs

04/12/2023 Description of buyback programs

Buyback programs - december 2023

Monthly communication regarding buyback programs

03/12/2023 Description of buyback programs

Buyback programs - october 2023

Monthly communication regarding buyback programs

06/11/2023 Description of buyback programs